However, since we and others have been unable to make other statins work against HBV, such as fluvastatin (Korba, unpublished results),
pravastatin (Bader, unpublished results),
or lovastatin (Lin et al., 2003), the reduction of mevalonate is unlikely to be the sole source of anti-HBV effect.